Drawing for ACCELOR

USPTO serial 87112039

ACCELOR

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
GANDARA, KEYLA MARIA
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ACCELOR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Sarah M. Robertson

SARAH M. ROBERTSON DORSEY & WHITNEY LLP51 WEST 52ND STREETNEW YORK, NY 10019-6119UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Excipients for use in the manufacture of pharmaceutical preparations and/or dietary supplementsACTIVE—
005Dietary and nutritional supplements; dietary and nutritional supplements for endurance sports; medicinal oils; dietetic foods, namely, omega 3 capsules, tablets, gels, chewables, smoothies, enteral feed formulas, liquid nutritive preparations for oral or tube feeding and nutritional bars with omega-3 formulation, adapted for medical purposes; biological preparations for the treatment or prevention of cancer, cachexia, concussion, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), rheumatoid arthritis, hypertriglyceridemia (HTG), metabolic syndrome, sarcopenia, chronic inflammatory diseases and diabetes; dietetic beverages adapted for nutritional support for the treatment or prevention of cancer, cachexia, concussion, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), rheumatoid arthritis, hypertriglyceridemia (HTG), metabolic syndrome, sarcopenia, chronic inflammatory diseases and diabetes; dietetic substances, namely, omega-3 concentrate adapted for medical use; nutritional supplements adapted for medical use; nutritional supplements; food supplements for medical purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Mar 23, 2020MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 23, 2020ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 13, 2019ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jun 11, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 7, 2019EX4GSOU EXTENSION 4 GRANTED—
Jun 7, 2019EXT4SOU EXTENSION 4 FILED—
Jun 7, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 24, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 22, 2019EX3GSOU EXTENSION 3 GRANTED—
Jan 22, 2019EXT3SOU EXTENSION 3 FILED—
Jan 22, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 7, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 5, 2018EX2GSOU EXTENSION 2 GRANTED—
Jul 5, 2018EXT2SOU EXTENSION 2 FILED—
Jul 5, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 8, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 6, 2018EX1GSOU EXTENSION 1 GRANTED—
Feb 6, 2018EXT1SOU EXTENSION 1 FILED—
Feb 6, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 15, 2017NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 20, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 20, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 31, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 9, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 9, 2017XAECEXAMINER'S AMENDMENT ENTERED—
May 9, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 9, 2017GNEAEXAMINERS AMENDMENT E-MAILED—
May 9, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
May 9, 2017XAECEXAMINER'S AMENDMENT ENTERED—
May 9, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 9, 2017GNEAEXAMINERS AMENDMENT E-MAILED—
May 9, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 6, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 5, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 5, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 12, 2016GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 12, 2016GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 12, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 6, 2016DOCKASSIGNED TO EXAMINER—
Jul 27, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 25, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance